Genetic Variation That Raises Risk of Serious Complication Linked to Osteoporosis Drugs Identified

Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.

More...